The emerging roles of Notch signaling in leukemia and stem cells
Open accessThe DOI matches its Crossref record; 78 of the 78 references it cites were found in a registry or an index.
Abstract
The Notch signaling pathway plays a critical role in maintaining the balance between cell proliferation, differentiation and apoptosis, and is a highly conserved signaling pathway that regulates normal development in a context- and dose-dependent manner. Dysregulation of Notch signaling has been suggested to be key events in a variety of hematological malignancies. Notch1 signaling appears to be the central oncogenic trigger in T cell acute lymphoblastic leukemia (T-ALL), in which the majority of human malignancies have acquired mutations that lead to constitutive activation of Notch1 signaling. However, emerging evidence unexpectedly demonstrates that Notch signaling can function as a potent tumor suppressor in other forms of leukemia. This minireview will summarize recent advances related to the roles of activated Notch signaling in human lymphocytic leukemia, myeloid leukemia, stem cells and stromal microenvironment, and we will discuss the perspectives of Notch signaling as a potential therapeutic target as well.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, Notch signaling functions as a tumor suppressor in the malignancies of myeloid origin, such as acute myelogenous leukemia and chronic myeloid leukemia [138, 139].”
From Tumor microenvironment signaling and therapeutics in cancer progression (2023) · cites this paper as [139]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Wang, Z., Banerjee, S., Li, Y., Rahman, K. M. W., Zhang, Y., & Sarkar, F. H. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4281 · Cited by 307 · cited 2×
“, some of which are dependent on Notch signaling in multiple tissues, while others are tissue specific [8-21] (Table 1).”
BackgroundRetractedActivating Mutations of NOTCH1 in Human T Cell Acute Lymphoblastic Leukemia
Weng, A. P., Ferrando, A. A., Lee, W., Morris, J. P., Silverman, L. B., Sanchez-Irizarry, C., Blacklow, S. C., Look, A. T., & Aster, J. C. (2004) · Science · doi:10.1126/science.1102160 · Cited by 2,715 · cited 1×
“Notch1 mutations causing Notch signaling continuously activated have been found in nearly 60% of T cell acute lymphoblastic leukemia (T-ALL) patients, making Notch1 the most prominent oncogene specifically involved in the pathogenesis of T-ALL [24,25].”
BackgroundHES and HERP families: Multiple effectors of the notch signaling pathway
Iso, T., Kedes, L., & Hamamori, Y. (2003) · Journal of Cellular Physiology · doi:10.1002/jcp.10208 · Cited by 1,238 · cited 1×
“The best-known Notch target genes are two families of basic helixloop helix transcription factors: Hes (Hairy enhance of split) and Hey (Hairy/enhancer of spit related with YRPW motif) family [7].”
Backgroundc-Myc is an important direct target of Notch1 in T-cell acute lymphoblastic leukemia/lymphoma
Weng, A. P., Millholland, J. M., Yashiro-Ohtani, Y., Arcangeli, M. L., Lau, A., Wai, C., del Bianco, C., Rodriguez, C. G., Sai, H., Tobias, J., et al. (2006) · Genes & Development · doi:10.1101/gad.1450406 · Cited by 870 · cited 6×
“Moreover, our previous study has shown that Notch1 signaling is also required for hypoxia-induced proliferation, invasion and chemoresistance in T-ALL, suggesting that pharmacological inhibitors of Notch1 signaling may be attractive interventions for T-ALL treatment [30].”
BackgroundInfluentialTherapeutic antibody targeting of individual Notch receptors
Wu, Y., Cain-Hom, C., Choy, L., Hagenbeek, T. J., de Leon, G. P., Chen, Y., Finkle, D., Venook, R., Wu, X., Ridgway, J., et al. (2010) · Nature · doi:10.1038/nature08878 · Cited by 720 · cited 2×
“Several strategies have been proposed to inhibit or modulate this signaling [73,74].”
BackgroundSelf-citationFehon, R. G., Kooh, P. J., Rebay, I., Regan, C. L., Xu, T., Muskavitch, M. A. T., & Artavanis-Tsakonas, S. (1990) · Cell · doi:10.1016/0092-8674(90)90534-l · Cited by 673 · cited 1×
“Notch signaling has been shown to be initiated by binding of the Notch transmembrane receptors with their specific ligands between two neighboring cells [6].”
BackgroundO'Neil, J., Grim, J., Strack, P., Rao, S., Tibbitts, D., Winter, C., Hardwick, J., Welcker, M., Meijerink, J. P., Pieters, R., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070876 · Cited by 663 · cited 5×
“The most widely used drug to globally inhibit Notch signaling is GSIs, which block the cleavage of Notch at the cell membrane, inhibiting release of the transcriptionally active Notch intracellular domain (NICD) subunit.”
BackgroundInfluentialThe Notch signaling pathway: Transcriptional regulation at Notch target genes
Borggrefe, T., & Oswald, F. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-009-8668-7 · Cited by 661 · cited 2×
“, some of which are dependent on Notch signaling in multiple tissues, while others are tissue specific [8-21] (Table 1).”
BackgroundNotch4/int-3, a mammary proto-oncogene, is an endothelial cell-specific mammalian Notch gene
Uyttendaele, H., Marazzi, G., Wu, G., Yan, Q., Sassoon, D., & Kitajewski, J. (1996) · Development · doi:10.1242/dev.122.7.2251 · Cited by 485
γ-secretase inhibitors reverse glucocorticoid resistance in T cell acute lymphoblastic leukemia
Real, P. J., Tosello, V., Palomero, T., Castillo, M., Hernando, E., de Stanchina, E., Sulis, M. L., Barnes, K., Sawai, C., Homminga, I., et al. (2009) · Nature Medicine · doi:10.1038/nm.1900 · Cited by 445 · cited 1×
“However, in an attempt to the clinical application of GSIs, dexamethasone was found to abrogate GSI-induced toxicity in the gut and as well GSIs treatment could reverse glucocorticoid resistance in T-ALL patients [77].”
Background
Cited by
Tumor microenvironment signaling and therapeutics in cancer progression
Goenka, A., Khan, F., Verma, B., Sinha, P., Dmello, C. C., Jogalekar, M. P., Gangadaran, P., & Ahn, B. (2023) · Cancer Communications · doi:10.1002/cac2.12416 · Cited by 323
“However, Notch signaling functions as a tumor suppressor in the malignancies of myeloid origin, such as acute myelogenous leukemia and chronic myeloid leukemia [138, 139].”
BackgroundNon-Canonical Notch Signaling in Cancer and Immunity
Ayaz, F., & Osborne, B. A. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00345 · Cited by 163
Targeting acute myeloid leukemia stem cell signaling by natural products
Siveen, K. S., Uddin, S., & Mohammad, R. M. (2017) · Molecular Cancer · doi:10.1186/s12943-016-0571-x · Cited by 162
“The target genes of Notch involved in cell cycle regulation (cyclin D1, cyclin A , p21, p27), cell proliferation and survival (c-myc, NF-κB2 , Akt, mTOR), embryonic development (Hes1, Hes6), angiopoiesis (VEGF, VEGFR-2), invasion and metastasis (MMP-9, MMP-2) [60].”
Singh, A. K., Sharma, N., Ghosh, M., Park, Y. H., & Jeong, D. K. (2017) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2015.1129310 · Cited by 85
“Activation of Notch1/2 resulted in tumor suppressive effect in NSCLC and chronic myelomonocytic leukemia (CML) cell lines (Liu et al., 2013).”
BackgroundOncodriveROLE classifies cancer driver genes in loss of function and activating mode of action
Schroeder, M. P., Rubio-Perez, C., Tamborero, D., Gonzalez-Perez, A., & Lopez-Bigas, N. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btu467 · Cited by 60
Metadata
- Authors
- Liu, N., Zhang, J., & Ji, C.
- Affiliations
- Shandong University (CN)
- Corresponding author
- Ji, Chunyan
- Venue
- Biomarker Research
- Published
- 2013-07-18
- Volume
- 1
- Issue
- 1
- Pages
- 23-23
- ISSN
- 2050-7771 (ISSN-L)
- PMC
- PMC4177577
- OpenAlex
- W2113473901
- Cited by
- 39
- References
- 78
- Citations by year
- 2024: 1 · 2023: 3 · 2022: 5 · 2021: 2 · 2020: 3 · 2019: 4 · 2018: 5 · 2017: 2 · 2016: 4 · 2015: 5 · 2014: 5
- FWCI
- 2.09
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- Biomarker Research (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
- Health Sciences › Medicine › Hematology › Acute Lymphoblastic Leukemia research
- Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
- Keywords
- Notch signaling, Notch1, T-cell acute lymphoblastic leukemia, lymphocytic leukemia, myeloid leukemia, hematopoietic stem cells, tumor suppressor function, stromal microenvironment, therapeutic target
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The emerging roles of Notch signaling in leukemia and stem cells. https://app.cochat.ai/papers/10.1186/2050-7771-1-23
- The paper
- Liu, N., Zhang, J., & Ji, C. (2013). The emerging roles of Notch signaling in leukemia and stem cells. Biomarker Research. https://doi.org/10.1186/2050-7771-1-23
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
